Fibroblast growth factor 2 regulates adequate nigrostriatal pathway formation in mice

Journal of Comparative Neurology

Volumn 520, Issue 17, 2012, Pages 3949-3961

  Baron, Olga ^a,b   Ratzka, Andreas ^a   Grothe, Claudia ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

Dopaminergic neuron; Neural development; Neurotrophic factor; Organotypic cocultures; Parkinson's disease; Substantia nigra

Indexed keywords

FIBROBLAST GROWTH FACTOR 2;

ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CELL CULTURE; COCULTURE; CONTROLLED STUDY; EMBRYO; HOMOZYGOSITY; IMMUNOCYTOCHEMISTRY; MOUSE; NEWBORN; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TRANSGENIC MOUSE;

ANIMALS; COCULTURE TECHNIQUES; CORPUS STRIATUM; FIBROBLAST GROWTH FACTOR 2; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURAL PATHWAYS; NEUROGENESIS; SUBSTANTIA NIGRA;

EID: 84867112176     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.23138     Document Type: Article

References (73)

1. Alberi L, Sgado P, Simon HH. 2004. Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons. Development 131: 3229-3236.
2. Amalric F, Baldin V, Bosc-Bierne I, Bugler B, Couderc B, Guyader M, Patry V, Prats H, Roman AM, Bouche G. 1991. Nuclear translocation of basic fibroblast growth factor. Ann N Y Acad Sci 638: 127-138.
3. Bean AJ, Elde R, Cao YH, Oellig C, Tamminga C, Goldstein M, Pettersson RF, Hokfelt T. 1991. Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human. Proc Natl Acad Sci USA 88: 10237-10241.
4. Bean AJ, Oellig C, Pettersson RF, Hokfelt T. 1992. Differential expression of acidic and basic FGF in the rat substantia nigra during development. Neuroreport 3: 993-996.
5. Bishop NA, Lu T, Yankner BA. 2010. Neural mechanisms of ageing and cognitive decline. Nature 464: 529-535.
6. Bjerken S, Boger HA, Nelson M, Hoffer BJ, Granholm AC, Stromberg I. 2007. Effects of glial cell line-derived neurotrophic factor deletion on ventral mesencephalic organotypic tissue cultures. Brain Res 1133: 10-19.
7. Blakely BD, Bye CR, Fernando CV, Horne MK, Macheda ML, Stacker SA, Arenas E, Parish CL. 2011. Wnt5a regulates midbrain dopaminergic axon growth and guidance. PLoS One 6: e18373.
8. Bribian A, Barallobre MJ, Soussi-Yanicostas N, de Castro F. 2006. Anosmin-1 modulates the FGF-2-dependent migration of oligodendrocyte precursors in the developing optic nerve. Mol Cell Neurosci 33: 2-14.
9. Bugler B, Amalric F, Prats H. 1991. Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol Cell Biol 11: 573-577.
10. Burke RE. 2003. Postnatal developmental programmed cell death in dopamine neurons. Ann N Y Acad Sci 991: 69-79.
11. Burke RE. 2004. Ontogenic cell death in the nigrostriatal system. Cell Tissue Res 318: 63-72.
12. Burke RE. 2006. GDNF as a candidate striatal target-derived neurotrophic factor for the development of substantia nigra dopamine neurons. J Neural Transm Suppl 70: 41-45.
13. Chadi G, Moller A, Rosen L, Janson AM, Agnati LA, Goldstein M, Ogren SO, Pettersson RF, Fuxe K. 1993. Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion. Exp Brain Res 97: 145-158.
14. Cintra A, Cao Y, Oellig C, Tinner B, Bortolotti F, Goldstein M, Pettersson RF, Fuxe K. 1991. Basic FGF is present in dopaminergic neurons of the ventral midbrain of the rat. Neuroreport 2: 597-600.
15. Claus P, Bruns AF, Grothe C. 2004a. Fibroblast growth factor-2(23) binds directly to the survival of motoneuron protein and is associated with small nuclear RNAs. Biochem J 384(Pt 3): 559-565.
16. Claus P, Werner S, Timmer M, Grothe C. 2004b. Expression of the fibroblast growth factor-2 isoforms and the FGF receptor 1-4 transcripts in the rat model system of Parkinson's disease. Neurosci Lett 360: 117-120.
17. Dai Z, Peng HB. 1995. Presynaptic differentiation induced in cultured neurons by local application of basic fibroblast growth factor. J Neurosci 15: 5466-5475.
18. Dono R. 2003. Fibroblast growth factors as regulators of central nervous system development and function. Am J Physiol Regul Integr Comp Physiol 284: R867-881.
19. Dono R, Texido G, Dussel R, Ehmke H, Zeller R. 1998. Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. EMBO J 17: 4213-4225.
20. Easton RM, Deckwerth TL, Parsadanian AS, Johnson EM Jr. 1997. Analysis of the mechanism of loss of trophic factor dependence associated with neuronal maturation: a phenotype indistinguishable from Bax deletion. J Neurosci 17: 9656-9666.
21. Ferguson IA, Johnson EM. 1991. Fibroblast growth factor receptor-bearing neurons in the CNS: identification by receptor-mediated retrograde transport. J Comp Neurol 313: 693-706.
22. Ferrari G, Minozzi MC, Toffano G, Leon A, Skaper SD. 1989. Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Dev Biol 133: 140-147.
23. Florkiewicz RZ, Baird A, Gonzalez AM. 1991. Multiple forms of bFGF: differential nuclear and cell surface localization. Growth Factors 4: 265-275.
24. Ford-Perriss M, Abud H, Murphy M. 2001. Fibroblast growth factors in the developing central nervous system. Clin Exp Pharmacol Physiol 28: 493-503.
25. Garzon M, Pickel VM. 2006. Subcellular distribution of M2 muscarinic receptors in relation to dopaminergic neurons of the rat ventral tegmental area. J Comp Neurol 498: 821-839.
26. Giordano S, Sherman L, Lyman W, Morrison R. 1992. Multiple molecular weight forms of basic fibroblast growth factor are developmentally regulated in the central nervous system. Dev Biol 152: 293-303.
27. Gonzalez AM, Buscaglia M, Ong M, Baird A. 1990. Distribution of basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues. J Cell Biol 110: 753-765.
28. Gonzalez AM, Berry M, Maher PA, Logan A, Baird A. 1995. A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brain. Brain Res 701: 201-226.
29. Grothe C, Timmer M. 2007. The physiological and pharmacological role of basic fibroblast growth factor in the dopaminergic nigrostriatal system. Brain Res Rev 54: 80-91.
30. Guillemot F, Zimmer C. 2011. From cradle to grave: the multiple roles of fibroblast growth factors in neural development. Neuron 71: 574-588.
31. Guo JU, Ma DK, Mo H, Ball MP, Jang MH, Bonaguidi MA, Balazer JA, Eaves HL, Xie B, Ford E, Zhang K, Ming GL, Gao Y, Song H. 2011. Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat Neurosci 14: 1345-1351.
32. Hermanson E, Borgius L, Bergsland M, Joodmardi E, Perlmann T. 2006. Neuropilin1 is a direct downstream target of Nurr1 in the developing brain stem. J Neurochem 97: 1403-1411.
33. Hernandez-Montiel HL, Tamariz E, Sandoval-Minero MT, Varela-Echavarria A. 2008. Semaphorins 3A, 3C, and 3F in mesencephalic dopaminergic axon pathfinding. J Comp Neurol 506: 387-397.
34. Itoh N, Ornitz DM. 2011. Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J Biochem 149: 121-130.
35. Jackson-Lewis V, Vila M, Djaldetti R, Guegan C, Liberatore G, Liu J, O'Malley KL, Burke RE, Przedborski S. 2000. Developmental cell death in dopaminergic neurons of the substantia nigra of mice. J Comp Neurol 424: 476-488.
36. Johansson S, Stromberg I. 2003. Fetal lateral ganglionic eminence attracts one of two morphologically different types of tyrosine hydroxylase-positive nerve fibers formed by cultured ventral mesencephalon. Cell Transplant 12: 243-255.
37. Jungnickel J, Klutzny A, Guhr S, Meyer K, Grothe C. 2005. Regulation of neuronal death and calcitonin gene-related peptide by fibroblast growth factor-2 and FGFR3 after peripheral nerve injury: evidence from mouse mutants. Neuroscience 134: 1343-1350.
38. Kholodilov N, Yarygina O, Oo TF, Zhang H, Sulzer D, Dauer W, Burke RE. 2004. Regulation of the development of mesencephalic dopaminergic systems by the selective expression of glial cell line-derived neurotrophic factor in their targets. J Neurosci 24: 3136-3146.
39. Klejbor I, Myers JM, Hausknecht K, Corso TD, Gambino AS, Morys J, Maher PA, Hard R, Richards J, Stachowiak EK, Stachowiak MK. 2006. Fibroblast growth factor receptor signaling affects development and function of dopamine neurons - inhibition results in a schizophrenia-like syndrome in transgenic mice. J Neurochem 97: 1243-1258.
40. Kolk SM, Gunput RA, Tran TS, van den Heuvel DM, Prasad AA, Hellemons AJ, Adolfs Y, Ginty DD, Kolodkin AL, Burbach JP, Smidt MP, Pasterkamp RJ. 2009. Semaphorin 3F is a bifunctional guidance cue for dopaminergic axons and controls their fasciculation, channeling, rostral growth, and intracortical targeting. J Neurosci 29: 12542-12557.
41. Legeai-Mallet L, Benoist-Lasselin C, Delezoide AL, Munnich A, Bonaventure J. 1998. Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia. J Biol Chem 273: 13007-13014.
42. Li AJ, Suzuki S, Suzuki M, Mizukoshi E, Imamura T. 2002. Fibroblast growth factor-2 increases functional excitatory synapses on hippocampal neurons. Eur J Neurosci 16: 1313-1324.
43. Lin L, Rao Y, Isacson O. 2005. Netrin-1 and slit-2 regulate and direct neurite growth of ventral midbrain dopaminergic neurons. Mol Cell Neurosci 28: 547-555.
44. Ma X, Dang X, Claus P, Hirst C, Fandrich RR, Jin Y, Grothe C, Kirshenbaum LA, Cattini PA, Kardami E. 2007. Chromatin compaction and cell death by high molecular weight FGF-2 depend on its nuclear localization, intracrine ERK activation, and engagement of mitochondria. J Cell Physiol 213: 690-698.
45. Majd S, Smardencas A, Parish CL, Drago J. 2011. Development of an in vitro model to evaluate the regenerative capacity of adult brain-derived tyrosine hydroxylase-expressing dopaminergic neurons. Neurochem Res 36: 967-977.
46. Maric D, Fiorio Pla A, Chang YH, Barker JL. 2007. Self-renewing and differentiating properties of cortical neural stem cells are selectively regulated by basic fibroblast growth factor (FGF) signaling via specific FGF Receptors. J Neurosci 27: 1836-1852.
47. Mason I. 2007. Initiation to end point: the multiple roles of fibroblast growth factors in neural development. Nat Rev Neurosci 8: 583-596.
48. McFarlane S, McNeill L, Holt CE. 1995. FGF signaling and target recognition in the developing Xenopus visual system. Neuron 15: 1017-1028.
49. McGeer EG, Singh EA, McGeer PL. 1992. Apparent anterograde transport of basic fibroblast growth factor in the rat nigrostriatal dopamine system. Neurosci Lett 148: 31-33.
50. Montero JA, Ganan Y, Macias D, Rodriguez-Leon J, Sanz-Ezquerro JJ, Merino R, Chimal-Monroy J, Nieto MA, Hurle JM. 2001. Role of FGFs in the control of programmed cell death during limb development. Development 128: 2075-2084.
51. Nakamura S, Ito Y, Shirasaki R, Murakami F. 2000. Local directional cues control growth polarity of dopaminergic axons along the rostrocaudal axis. J Neurosci 20: 4112-4119.
52. Northcutt KV, Wang Z, Lonstein JS. 2007. Sex and species differences in tyrosine hydroxylase-synthesizing cells of the rodent olfactory extended amygdala. J Comp Neurol 500: 103-115.
53. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M. 1996. Receptor specificity of the fibroblast growth factor family. J Biol Chem 271: 15292-15297.
54. Otto D, Unsicker K. 1990. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J Neurosci 10: 1912-1921.
55. Paxinos G, Franklin KB. 2001. The mouse brain in stereotaxic coordinates. Sydney, Australia: Academic Press. p 155-160.
56. Prakash N, Wurst W. 2006. Development of dopaminergic neurons in the mammalian brain. Cell Mol Life Sci 63: 187-206.
57. Quarto N, Finger FP, Rifkin DB. 1991. The NH2-terminal extension of high molecular weight bFGF is a nuclear targeting signal. J Cell Physiol 147: 311-318.
58. Ratzka A, Baron O, Grothe C. 2011. FGF-2 deficiency does not influence FGF ligand and receptor expression during development of the nigrostriatal system. PLoS One 6: e23564.
59. Ratzka A, Baron O, Stachowiak MK, Grothe C. 2012. FGF-2 regulates dopaminergic neuron development in vivo. J Neurochem [Epub ahead of print].
60. Saarimaki-Vire J, Peltopuro P, Lahti L, Naserke T, Blak AA, Vogt Weisenhorn DM, Yu K, Ornitz DM, Wurst W, Partanen J. 2007. Fibroblast growth factor receptors cooperate to regulate neural progenitor properties in the developing midbrain and hindbrain. J Neurosci 27: 8581-8592.
61. Shanmugalingam S, Houart C, Picker A, Reifers F, Macdonald R, Barth A, Griffin K, Brand M, Wilson SW. 2000. Ace/Fgf8 is required for forebrain commissure formation and patterning of the telencephalon. Development 127: 2549-2561.
62. Shirasaki R, Lewcock JW, Lettieri K, Pfaff SL. 2006. FGF as a target-derived chemoattractant for developing motor axons genetically programmed by the LIM code. Neuron 50: 841-853.
63. Stoppini L, Buchs PA, Muller D. 1991. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37: 173-182.
64. Timmer, Cesnulevicius K, Winkler C, Kolb J, Lipokatic-Takacs E, Jungnickel J, Grothe C. 2007. Fibroblast growth factor (FGF)-2 and FGF receptor 3 are required for the development of the substantia nigra, and FGF-2 plays a crucial role for the rescue of dopaminergic neurons after 6-hydroxydopamine lesion. J Neurosci 27: 459-471.
65. Tooyama I, Kawamata T, Walker D, Yamada T, Hanai K, Kimura H, Iwane M, Igarashi K, McGeer EG, McGeer PL. 1993. Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's disease. Neurology 43: 372-376.
66. Umemori H. 2009. Weaving the neuronal net with target-derived fibroblast growth factors. Dev Growth Differ 51: 263-270.
67. Voorn P, Kalsbeek A, Jorritsma-Byham B, Groenewegen HJ. 1988. The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience 25: 857-887.
68. Wallen A, Perlmann T. 2003. Transcriptional control of dopamine neuron development. Ann N Y Acad Sci 991: 48-60.
69. Webber CA, Hyakutake MT, McFarlane S. 2003. Fibroblast growth factors redirect retinal axons in vitro and in vivo. Dev Biol 263: 24-34.
70. Webber CA, Chen YY, Hehr CL, Johnston J, McFarlane S. 2005. Multiple signaling pathways regulate FGF-2-induced retinal ganglion cell neurite extension and growth cone guidance. Mol Cell Neurosci 30: 37-47.
71. Yamauchi K, Mizushima S, Tamada A, Yamamoto N, Takashima S, Murakami F. 2009. FGF8 signaling regulates growth of midbrain dopaminergic axons by inducing semaphorin 3F. J Neurosci 29: 4044-4055.
72. Yokoyama Y, Ozawa S, Seyama Y, Namiki H, Hayashi Y, Kaji K, Shirama K, Shioda M, Kano K. 1997. Enhancement of apoptosis in developing chick neural retina cells by basic fibroblast growth factor. J Neurochem 68: 2212-2215.
73. Zechel S, Unsicker K, von Bohlen Und Halbach O. 2009. Fibroblast growth factor-2 deficiency affects hippocampal spine morphology, but not hippocampal catecholaminergic or cholinergic innervation. Dev Dyn 238: 343-350.